National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A12AA03	CALCIUM GLUCONATE S.A.L.F	G	Calcium gluconate monohydrate - 10%	10%	Injectable solution	389,714 L.L
B03XA01	ALPEEN	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 40,000IU	40,000IU	Injectable solution	11,210,836 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	222,941 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	349,596 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	49,744,595 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	182,720 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	182,720 L.L
B05	20 MEQ POTASSIUM OF 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP	B	Dextrose, H2O - 5%, Sodium chloride - 0.45%, Potassium chloride - 20meq		Injectable solution	229,959 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	181,908 L.L
A03AX12	PHLOROGLUCINOL/TRIMETHYLPHLOROGLUCINOL ARROW	G	Phloroglucinol - 40mg/4ml, Trimethylphloroglucinol - 0.04mg/4ml		Injectable solution	940,690 L.L
B05	20 MEQ POTASSIUM OF 0.9% SODIUM CHLORIDE INJECTION USP	B	Sodium chloride - 0.9%, Potassium chloride - 20meq		Injectable solution	278,102 L.L
B05XA03	SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	156,288 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	2,998,113 L.L
B05	20 MEQ POTASSIUM OF 0.9% SODIUM CHLORIDE INJECTION USP	B	Sodium chloride - 0.9%, Potassium chloride - 20mEq		Injectable solution	229,959 L.L
B05XA03	SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	165,482 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	338,648 L.L
L01FG01	ZIRABEV	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	49,965,229 L.L
B05	SOLUFLEX POTASSIUM CHLORIDE 40meq/l SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%, Potassium chloride - 40meq/l		Injectable solution	293,041 L.L
B05XA03	SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	176,974 L.L
H02AB02	DEXAMEDIS FORT	G	Dexamethasone Phosphate - 8mg/2ml	8mg/2ml	Injectable solution	43,003 L.L
B05	SOLUFLEX POTASSIUM CHLORIDE 20meq/l SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%, Potassium chloride - 20meq/l		Injectable solution	232,134 L.L
B05XA03	SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	163,184 L.L
H02AB02	DEXAMETHASONE SODIUM PHOSPHATE USP - EIPICO	G	Dexamethasone (sodium phosphate) - 8mg/2ml	8mg/2ml	Injectable solution	185,450 L.L
B05AA01	ALBUTEIN	BioHuman	Human Albumin - 20%	20%	Injectable solution	7,154,928 L.L
B05XA03	SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	156,288 L.L
H02AB02	DEXASINA	G	Dexamethasone Phosphate - 8mg/2ml	8mg/2ml	Injectable solution	3,471,145 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	14,719,570 L.L
B05AA01	ALBUTEIN	BioHuman	Human Albumin - 20%		Injectable solution	4,031,528 L.L
B05XA03	SODIUM CHLORIDE INJECTION/ DEMO	G	Sodium chloride - 0.9% w/v	0.9% w/v	Injectable solution	1,182,581 L.L
H02AB02	RADOLINE	G	Dexamethasone sodium phosphate - 8mg/2ml	8mg/2ml	Injectable solution	3,711,565 L.L

National Cancer Registry (NCR)